ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,118.40
0.00%
Dow Jones
39,721.36
1.09%
Brent Oil
85.165
0.14%
Bitcoin
58,197.89
0.76%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
07/02/20217:51AMDow Jones NewsGlaxoSmithKline to Partner With US Company Alector on Neurodegenerative-Disease DrugsNYSE:GSKGSK plc
07/02/20217:38AMGlobeNewswire Inc.Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies...NYSE:GSKGSK plc
07/02/20217:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
07/02/20216:35AMDow Jones NewsGlaxoSmithKline Board Supports CEO in Response to Elliott CriticismNYSE:GSKGSK plc
07/01/202110:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
07/01/20215:50AMDow Jones NewsElliott Calls for Board Changes at GlaxoSmithKline Ahead of Consumer-Healthcare Spinoff -- UpdateNYSE:GSKGSK plc
07/01/20214:28AMDow Jones NewsElliott Calls for Board Changes at GlaxoSmithKline Ahead of SeparationNYSE:GSKGSK plc
06/30/20216:54AMDow Jones NewsGlaxoSmithKline, Vir to Supply Covid-19 Treatment to SingaporeNYSE:GSKGSK plc
06/29/20211:04PMPR Newswire (US)TUMS® Fuels the Autoburn, a Road Trip to America's Spiciest Destinations, with Hot Food Expert Sean EvansNYSE:GSKGSK plc
06/25/20212:01PMEdgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:GSKGSK plc
06/25/20211:51PMEdgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:GSKGSK plc
06/24/202110:48AMTipRanksGSK to Spin-Off Consumer Healthcare Business by Mid-2022; Provides OutlookNYSE:GSKGSK plc
06/23/202112:20PMDow Jones NewsFTSE 100 Closed Down Despite Outperforming European IndexesNYSE:GSKGSK plc
06/23/20218:32AMDow Jones NewsGlaxoSmithKline Expects Long-Term Sales, Profit Growth, Driven by Vaccines and Specialty Medicines -- UpdateNYSE:GSKGSK plc
06/23/20216:49AMDow Jones NewsGlaxoSmithKline Expects Sales, Profit to Grow Through 2026, Driven by Vaccines, Specialty MedicinesNYSE:GSKGSK plc
06/22/20212:37AMDow Jones NewsGlaxoSmithKline Says ViiV, Halozyme Signed Deal for Drug-Delivery TechnologyNYSE:GSKGSK plc
06/22/20212:18AMPR Newswire (US)ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enabl...NYSE:GSKGSK plc
06/21/20217:06AMGlobeNewswire Inc.GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for SotrovimabNYSE:GSKGSK plc
06/18/202110:45PMDow Jones NewsThe Week Ahead -- Barron'sNYSE:GSKGSK plc
06/18/202110:45PMDow Jones NewsThe Week Ahead -- Barron'sNYSE:GSKGSK plc
06/18/202110:28PMDow Jones NewsThe Week Ahead -- Barron'sNYSE:GSKGSK plc
06/18/202110:00PMDow Jones NewsThe Week Ahead -- Barron'sNYSE:GSKGSK plc
06/16/20216:26PMDow Jones NewsCureVac Reports Unfavorable Covid-19 Vaccine Study Results Amid High Levels of VariantsNYSE:GSKGSK plc
06/16/20215:55PMDow Jones NewsCureVac Down 52% After Hours on Interim Covid-19 Vaccine Study DataNYSE:GSKGSK plc
06/14/202110:40AMDow Jones NewsiTeos Therapeutics Shares Rise 32% on Deal With GlaxoSmithKlineNYSE:GSKGSK plc
06/14/20217:22AMDow Jones NewsGlaxoSmithKline, ITeos Therapeutics Team Up to Develop Immuno-Oncology DrugNYSE:GSKGSK plc
06/14/20217:00AMGlobeNewswire Inc.iTeos Therapeutics and GSK announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal ant...NYSE:GSKGSK plc
06/11/20212:21PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/04/20211:43PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/04/202111:43AMDow Jones NewsGlaxoSmithKline Advises ADS Holders to Reject TRC Capital Tender OfferNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
AXXA
Exxe (PK)
USOTC
VXIT
Virexit Technologies (PK)
AMEX
SPY
SPDR S&P 500
USOTC
RNVA
Rennova Health (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved